InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
2
T+90 hit rate
50%
T+90 mean return
+10.0%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Gosebruch Henry O, Director. Officer active across 3 companies, notably AbbVie Inc.. Cumulatively, 12 filings have been recorded. Breakdown: 2 buys · 2 sells. Total volume traded: €5.1m. Activity tracked since 7 September 2021. The latest transaction was filed on 14 February 2024 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations12 total
50,000 sharesCommon StockSEC:0001962918-25-000058:0
80,000 shares0Common StockSEC:0001610717-24-000065:0
15,000 shares@ US$12.6247100.0% of flowCommon StockSEC:0001610717-23-000290:0
Canonical exit: 18 Dec 2023 (T+90)
50,000 shares@ US$18.00100.0% of flowCommon StockSEC:0001209191-23-028878:0
Canonical exit: 7 Aug 2023 (T+90)
83,960 shares@ US$54.860.0012% mcap26.0% of flowCommon Stock, $0.01 par valueSEC:0001179110-22-003108:0
15,733 shares@ US$146.81050.0006% mcap12.1% of flowCommon Stock, $0.01 par valueSEC:0001179110-22-003107:0
83,960 shares@ US$54.860.0012% mcap26.0% of flowCommon Stock, $0.01 par valueSEC:0001179110-22-003076:0
15,733 shares@ US$146.81050.0006% mcap12.1% of flowCommon Stock, $0.01 par valueSEC:0001179110-22-001923:0
30,156 shares@ US$149.540.0011% mcap23.7% of flowCommon Stock, $0.01 par valueSEC:0001179110-22-001841:0
36,673 shares0Common Stock, $0.01 par valueSEC:0001179110-22-001513:0
30,000 shares0Common Stock, $0.01 par valueSEC:0001179110-21-008720:0
30,000 shares0Common Stock, $0.01 par valueSEC:0001179110-21-008720
12 of 12 declarations
About Gosebruch Henry O
Henry O. Gosebruch is EVP and Chief Strategy Officer at AbbVie Inc. He oversees the company's strategy and contributes to strategic planning. His role is essential in ensuring growth and innovation at AbbVie.
